Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.

doi:10.1016/s0304-3835(00)00381-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.

Cancer letters - 29 May 2000

Huncharek M, Kupelnick B, Geschwind J F, Caubet J F

Abstract excerpt

Mutation of the p53 tumor suppressor gene is considered a possible marker of poor survival among patients with non-small cell lung cancer (NSCLC). This report presents the results of a meta-analysis of the available data addressing this issue. Using previously described methods, a protocol was developed for a meta-analysis examining the prognostic significance of p53 mutations in NSCLC. Two-year survival data...

Topics

Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Humans
Lung Neoplasms
Mutation
Polymorphism, Single-Stranded Conformational
Prognosis
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 10779652
DOI: 10.1016/s0304-3835(00)00381-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics